Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 46

1.

Drug-Drug Interactions of Glecaprevir and Pibrentasvir Coadministered with Human Immunodeficiency Virus Antiretrovirals.

Kosloski MP, Oberoi R, Wang S, Viani RM, Asatryan A, Hu B, Ding B, Qi X, Kim EJ, Mensa F, Kort J, Liu W.

J Infect Dis. 2019 Aug 29. pii: jiz439. doi: 10.1093/infdis/jiz439. [Epub ahead of print]

PMID:
31504702
2.

Long-Term Safety and Efficacy of Dolutegravir in Treatment-Experienced Adolescents With Human Immunodeficiency Virus Infection: Results of the IMPAACT P1093 Study.

Viani RM, Ruel T, Alvero C, Fenton T, Acosta EP, Hazra R, Townley E, Palumbo P, Buchanan AM, Vavro C, Singh R, Graham B, Anthony P, George K, Wiznia A; P1093 Study Team .

J Pediatric Infect Dis Soc. 2019 Apr 5. pii: piy139. doi: 10.1093/jpids/piy139. [Epub ahead of print]

PMID:
30951600
3.

Ombitasvir/Paritaprevir/Ritonavir With or Without Dasabuvir and With or Without Ribavirin for Adolescents With HCV Genotype 1 or 4.

Leung DH, Wirth S, Yao BB, Viani RM, Gonzalez-Peralta RP, Jonas MM, Lobritto SJ, Narkewicz MR, Sokal E, Fortuny C, Hsu EK, Del Valle-Segarra A, Zha J, Larsen L, Liu L, Shuster DL, Cohen DE, Rosenthal P.

Hepatol Commun. 2018 Oct 5;2(11):1311-1319. doi: 10.1002/hep4.1250. eCollection 2018 Nov.

4.

Ombitasvir/paritaprevir/ritonavir+dasabuvir+ribavirin for chronic hepatitis C virus genotype 1b-infected cirrhotics (TURQUOISE-IV).

Isakov V, Paduta D, Viani RM, Enejosa JV, Pasechnikov V, Znoyko O, Ogurtsov P, Bogomolov PO, Maevskaya MV, Chen X, Shulman NS.

Eur J Gastroenterol Hepatol. 2018 Sep;30(9):1073-1076. doi: 10.1097/MEG.0000000000001166.

PMID:
29762255
5.

Efficacy and Safety of Glecaprevir/Pibrentasvir in Patients Coinfected With Hepatitis C Virus and Human Immunodeficiency Virus Type 1: The EXPEDITION-2 Study.

Rockstroh JK, Lacombe K, Viani RM, Orkin C, Wyles D, Luetkemeyer AF, Soto-Malave R, Flisiak R, Bhagani S, Sherman KE, Shimonova T, Ruane P, Sasadeusz J, Slim J, Zhang Z, Samanta S, Ng TI, Gulati A, Kosloski MP, Shulman NS, Trinh R, Sulkowski M.

Clin Infect Dis. 2018 Sep 14;67(7):1010-1017. doi: 10.1093/cid/ciy220.

6.

A Phase 1 Study to Evaluate the Effect of Crushing, Cutting Into Half, or Grinding of Glecaprevir/Pibrentasvir Tablets on Exposures in Healthy Subjects.

Oberoi RK, Zhao W, Sidhu DS, Viani RM, Trinh R, Liu W.

J Pharm Sci. 2018 Jun;107(6):1724-1730. doi: 10.1016/j.xphs.2018.02.015. Epub 2018 Feb 21.

PMID:
29476763
7.

Child, Caregiver, and Health Care Provider Perspectives and Experiences Regarding Disclosure of HIV Status to Perinatally Infected Children in Lima, Peru.

Baker AN, Bayer AM, Kolevic L, Najarro L, Viani RM, Deville JG.

J Int Assoc Provid AIDS Care. 2018 Jan-Dec;17:2325957417752257. doi: 10.1177/2325957417752257.

PMID:
29347903
8.

Morbidity and Mortality of a Cohort of Peruvian HIV-infected Children 2003-2012.

Baker AN, Bayer AM, Viani RM, Kolevic L, Sim MS, Deville JG.

Pediatr Infect Dis J. 2018 Jun;37(6):564-569. doi: 10.1097/INF.0000000000001865.

9.

Comparison of the QuantiFERON TB Gold In-tube Assay With Tuberculin Skin Test for the Diagnosis of Latent Tuberculosis Infection Among HIV-infected and Uninfected Children.

Dehority W, Viani RM, Araneta MRG, Lopez G, Spector SA.

Pediatr Infect Dis J. 2017 Dec;36(12):e317-e321. doi: 10.1097/INF.0000000000001771.

PMID:
29140946
10.

Safety and Efficacy of Ombitasvir, Paritaprevir With Ritonavir ± Dasabuvir With or Without Ribavirin in Patients With Human Immunodeficiency Virus-1 and Hepatitis C Virus Genotype 1 or Genotype 4 Coinfection: TURQUOISE-I Part 2.

Rockstroh JK, Orkin C, Viani RM, Wyles D, Luetkemeyer AF, Lazzarin A, Soto-Malave R, Nelson MR, Bhagani SR, Klinker HHF, Rizzardini G, Girard PM, Tural C, Shulman NS, Mobashery N, Hu YB, Fredrick LM, Pilot-Matias T, Trinh R, Gane E.

Open Forum Infect Dis. 2017 Jul 22;4(3):ofx154. doi: 10.1093/ofid/ofx154. eCollection 2017 Summer.

11.

TURQUOISE-I Part 1b: Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir with Ribavirin for Hepatitis C Virus Infection in HIV-1 Coinfected Patients on Darunavir.

Wyles D, Saag M, Viani RM, Lalezari J, Adeyemi O, Bhatti L, Khatri A, King JR, Hu YB, Trinh R, Shulman NS, Ruane P.

J Infect Dis. 2017 Feb 15;215(4):599-605. doi: 10.1093/infdis/jiw597.

PMID:
28329334
12.
13.

Chest Pain and Shortness of Breath in a Previously Healthy Teenager.

Chaparro J, Murphy E, Davis C, Viani RM, Pong A.

J Pediatric Infect Dis Soc. 2015 Jun;4(2):171-3. doi: 10.1093/jpids/piu036. Epub 2014 May 3. No abstract available.

PMID:
26407419
14.

Safety, Pharmacokinetics and Efficacy of Dolutegravir in Treatment-experienced HIV-1 Infected Adolescents: Forty-eight-week Results from IMPAACT P1093.

Viani RM, Alvero C, Fenton T, Acosta EP, Hazra R, Townley E, Steimers D, Min S, Wiznia A; P1093 Study Team.

Pediatr Infect Dis J. 2015 Nov;34(11):1207-13. doi: 10.1097/INF.0000000000000848.

15.

Use of Integrase Inhibitors in HIV-Infected Children and Adolescents.

Dehority W, Abadi J, Wiznia A, Viani RM.

Drugs. 2015 Sep;75(13):1483-97. doi: 10.1007/s40265-015-0446-2. Review.

PMID:
26242765
16.

Lack of knowledge about mother-to-child HIV transmission prevention in pregnant women at Tijuana General Hospital, Baja California, Mexico.

Becka CM, Chacón-Cruz E, Araneta MR, Viani RM.

J Int Assoc Provid AIDS Care. 2015 Jan-Feb;14(1):72-6. doi: 10.1177/2325957414557262. Epub 2014 Oct 31.

PMID:
25361556
17.

In-Country Migration and Risk Factors for HIV Acquisition among Pregnant Women in Tijuana, Mexico.

Viani RM, Araneta MR, Spector SA.

J Int Assoc Provid AIDS Care. 2016 May;15(3):228-31. doi: 10.1177/2325957414539043. Epub 2014 Jun 16.

18.

HIV-1 phenotypic drug resistance testing among highly treatment experienced and poorly adherent youth.

Dehority W, Deville JG, Zilbermann JL, Viani RM.

Pediatr Infect Dis J. 2013 Oct;32(10):1158. doi: 10.1097/INF.0b013e31829f09cf. No abstract available.

PMID:
24067561
19.

Effect of HIV genotypic drug resistance testing on the management and clinical course of HIV-infected children and adolescents.

Dehority W, Deville JG, Lujan-Zilbermann J, Spector SA, Viani RM.

Int J STD AIDS. 2013 Jul;24(7):549-53. doi: 10.1177/0956462412473958. Epub 2013 Jul 4.

PMID:
23970770
20.

Letter to the editor: regarding "the emerging HIV epidemic on the Mexico-U.S. border: an international case study characterizing the role of epidemiology in surveillance and response".

Viani RM, Lopez G, Ruiz-Calderon J.

Ann Epidemiol. 2013 Apr;23(4):236-7. doi: 10.1016/j.annepidem.2012.12.003. Epub 2013 Jan 5. No abstract available.

PMID:
23294999
21.

Parallel rapid HIV testing in pregnant women at Tijuana General Hospital, Baja California, Mexico.

Viani RM, Araneta MR, Spector SA.

AIDS Res Hum Retroviruses. 2013 Mar;29(3):429-34. doi: 10.1089/AID.2012.0190. Epub 2012 Nov 19.

PMID:
23050550
22.

Clinical Outcomes and Hospitalizations among Children Perinatally Infected with HIV-1 in Baja California, Mexico.

Viani RM, Araneta MR, Lopez G, Chacón-Cruz E, Spector SA.

J Int Assoc Physicians AIDS Care (Chic). 2011 Jul-Aug;10(4):223-8. doi: 10.1177/1545109711409942. Epub 2011 Jun 20.

PMID:
21690301
23.

Mother-to-child HIV transmission in a cohort of pregnant women diagnosed by rapid HIV testing at Tijuana General Hospital, Baja California, Mexico.

Viani RM, Ruiz-Calderon J, Lopez G, Chacón-Cruz E, Spector SA.

J Int Assoc Physicians AIDS Care (Chic). 2010 Mar-Apr;9(2):82-6. doi: 10.1177/1545109710363920. Epub 2010 Mar 24.

PMID:
20335496
24.
25.

Potential confounding of the association between exposure to nucleoside analogues and mitochondrial dysfunction in HIV-uninfected and indeterminate infants.

Brogly SB, Foca M, Deville JG, Mirochnick M, Scott GB, Mofenson LM, Read JS, Viani RM, Burchett SK, Cooper ER, Browning R, Shapiro DE.

J Acquir Immune Defic Syndr. 2010 Jan;53(1):154-7. doi: 10.1097/QAI.0b013e3181b3adc2. No abstract available.

26.

[Estimating the 2006 prevalence of HIV by gender and risk groups in Tijuana, Mexico].

Iñiguez-Stevens E, Brouwer KC, Hogg RS, Patterson TL, Lozada R, Magis-Rodríguez C, Elder JP, Viani RM, Strathdee SA.

Gac Med Mex. 2009 May-Jun;145(3):189-95. Spanish.

27.

Poor outcome is associated with delayed tuberculosis diagnosis in HIV-infected children in Baja California, Mexico.

Viani RM, Lopez G, Chacón-Cruz E, Hubbard P, Spector SA.

Int J Tuberc Lung Dis. 2008 Apr;12(4):411-6.

PMID:
18371267
28.

Clinical outcomes after an unstructured treatment interruption in children and adolescents with perinatally acquired HIV infection.

Saitoh A, Foca M, Viani RM, Heffernan-Vacca S, Vaida F, Lujan-Zilbermann J, Emmanuel PJ, Deville JG, Spector SA.

Pediatrics. 2008 Mar;121(3):e513-21. doi: 10.1542/peds.2007-1086.

PMID:
18310171
29.

Pharmacokinetics of antiretroviral regimens containing tenofovir disoproxil fumarate and atazanavir-ritonavir in adolescents and young adults with human immunodeficiency virus infection.

Kiser JJ, Fletcher CV, Flynn PM, Cunningham CK, Wilson CM, Kapogiannis BG, Major-Wilson H, Viani RM, Liu NX, Muenz LR, Harris DR, Havens PL; Adolescent Trials Network for HIV/AIDS Interventions.

Antimicrob Agents Chemother. 2008 Feb;52(2):631-7. Epub 2007 Nov 19.

30.

Prevalence of primary HIV-1 drug resistance in pregnant women and in newly diagnosed adults at Tijuana General Hospital, Baja California, Mexico.

Viani RM, Hsia K, Hubbard P, Ruiz-Calderon J, Lozada R, Alvelais J, Gallardo M, Spector SA.

Int J STD AIDS. 2007 Apr;18(4):235-8.

PMID:
17509172
31.

Performance of rapid HIV testing using Determine HIV-1/2 for the diagnosis of HIV infection during pregnancy in Tijuana, Baja California, Mexico.

Viani RM, Hubbard P, Ruiz-Calderon J, Araneta MR, Lopez G, Chacón-Cruz E, Spector SA.

Int J STD AIDS. 2007 Feb;18(2):101-4.

PMID:
17331281
32.

Prevalence of primary HIV-1 drug resistance among recently infected adolescents: a multicenter adolescent medicine trials network for HIV/AIDS interventions study.

Viani RM, Peralta L, Aldrovandi G, Kapogiannis BG, Mitchell R, Spector SA, Lie YS, Weidler JM, Bates MP, Liu N, Wilson CM; Adolescent Medicine Trials Network for HIV/AIDS Interventions.

J Infect Dis. 2006 Dec 1;194(11):1505-9. Epub 2006 Oct 20.

PMID:
17083034
33.

Migration and risk factors for HIV acquisition in pregnant women in Baja California, Mexico.

Viani RM, Araneta MR, Ruiz-Calderon J, Hubbard P, Lopez G, Chacón-Cruz E, Spector SA.

MedGenMed. 2005 Jun 22;7(2):69. No abstract available.

34.

Perinatal HIV counseling and rapid testing in Tijuana, Baja California, Mexico: seroprevalence and correlates of HIV infection.

Viani RM, Araneta MR, Ruiz-Calderon J, Hubbard P, Lopez G, Chacón-Cruz E, Spector SA.

J Acquir Immune Defic Syndr. 2006 Jan 1;41(1):87-92.

PMID:
16340479
35.

Treatment of infants coinfected with HIV-1 and cytomegalovirus with combination antiretrovirals and ganciclovir.

Saitoh A, Viani RM, Schrier RD, Spector SA.

J Allergy Clin Immunol. 2004 Oct;114(4):983-5. No abstract available.

PMID:
15480350
36.

Decrease in hospitalization and mortality rates among children with perinatally acquired HIV type 1 infection receiving highly active antiretroviral therapy.

Viani RM, Araneta MR, Deville JG, Spector SA.

Clin Infect Dis. 2004 Sep 1;39(5):725-31. Epub 2004 Aug 16.

PMID:
15356789
37.

HIV prevalence during pregnancy in Tijuana, Baja California, Mexico.

Viani RM, Calderon JR, Van Pratt C, Lopez G, Spector SA.

AIDS. 2003 May 2;17(7):1113-4. No abstract available.

PMID:
12700474
39.

Uveitis associated with Mycoplasma pneumoniae meningitis.

Yashar SS, Yashar B, Epstein E, Viani RM.

Acta Ophthalmol Scand. 2001 Feb;79(1):100-1. No abstract available.

40.

Gastrostomy tube insertion for improvement of adherence to highly active antiretroviral therapy in pediatric patients with human immunodeficiency virus.

Shingadia D, Viani RM, Yogev R, Binns H, Dankner WM, Spector SA, Chadwick EG.

Pediatrics. 2000 Jun;105(6):E80.

PMID:
10835093
41.

Resolution of HIV-associated nephrotic syndrome with highly active antiretroviral therapy delivered by gastrostomy tube.

Viani RM, Dankner WM, Muelenaer PA, Spector SA.

Pediatrics. 1999 Dec;104(6):1394-6. Review.

PMID:
10585995
42.

Lactoferrin inhibits HIV-1 replication in vitro and exhibits synergy when combined with zidovudine.

Viani RM, Gutteberg TJ, Lathey JL, Spector SA.

AIDS. 1999 Jul 9;13(10):1273-4. No abstract available.

PMID:
10416533
43.

Pediatric imported malaria in New York: delayed diagnosis.

Viani RM, Bromberg K.

Clin Pediatr (Phila). 1999 Jun;38(6):333-7. Review.

PMID:
10378090
44.

Obturator internus muscle abscess in children: report of seven cases and review.

Viani RM, Bromberg K, Bradley JS.

Clin Infect Dis. 1999 Jan;28(1):117-22. Review.

PMID:
10028081
45.
46.

Postoperative group B streptococcal necrotizing fasciitis in a previously healthy child.

Viani RM, Lewis A, Bradley JS.

Pediatr Infect Dis J. 1997 Jun;16(6):630-1. No abstract available.

PMID:
9194119

Supplemental Content

Loading ...
Support Center